Clinical evaluation of antiemetics for vomiting due to cancer chemotherapy in children
Ise, T.; Ohira, M.; Omiya, A.; Hirose, M.; Shibata, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(6): 1108-1118
1982
ISSN/ISBN: 0385-0684 PMID: 6764113 Document Number: 188372
Comparative study of antiemetic effect on vomiting due to cancer chemotherapy was performed in 62 children with various malignant diseases. Twenty-one children were treated with metoclopramide, 23 children with domperidone and remaining 18 children received methylprednisolone. Each drug was administered intravenously after administration of anticancer agents, and repeated if necessary. The most effective antiemetics was methyl-prednisolone with effective rate of 89% in comparison with 51% of domperidone and 17% of metoclopromide treated group, respectively. Methyl-prednisolone may be useful for severe vomiting due to anticancer drugs. Safer and significantly better therapeutic efficacy was observed in the group treated with domperidone than that with metoclopromide.